- Weight loss drugs like Ozempic and Zepbound are changing the treatment landscape for obesity and diabetes.
- A study found that people with HIV who took semaglutide, the active ingredient in Ozempic, for eight months showed signs of slower biological aging based on blood biomarkers.
- Researchers suggest that GLP-1 medications may also slow biological aging, but caution that evidence is still limited.
- Despite the potential, experts warn that side effects such as muscle loss and lower bone density could be significant as people age.
- Dr. Musi advises against using GLP-1 drugs off-label solely for longevity due to insufficient evidence.
- The findings indicate that these drugs could potentially reduce diseases linked to aging, suggesting they might improve longevity.
- Research shows that GLP-1 drugs may influence biological pathways involved in aging and reduce chronic inflammation.
- Early evidence of GLP-1 benefits for aging is mixed, but researchers believe the concept warrants further research.
- Several clinical trials are expected to begin shortly to study the drugs’ effects on various aging markers, including inflammation and biological age.
- The metabolic benefits of GLP-1 drugs are well demonstrated, and since metabolic health is linked to aging, these medications could influence aging.
- GLP-1 agonists combat inflammation, which is a driver of aging.
- While there is excitement about GLP-1 drugs, researchers caution that there is little evidence showing they extend lifespan in otherwise healthy individuals.
New research suggests that GLP-1 medications, including Ozempic, may slow biological aging, as evidenced by a study showing people with HIV taking semaglutide exhibited signs of slower aging based on blood biomarkers.237
However, experts like Dr. Musi caution against using these drugs off-label for longevity due to insufficient evidence. “I do not recommend taking GLP-1 drugs off-label solely to live longer because there isn’t enough evidence to support that use,” he stated.5
While early studies indicate potential benefits, including reduced chronic inflammation linked to age-related diseases, researchers emphasize that evidence is still limited.11
The metabolic advantages of GLP-1 drugs are well-documented, and since metabolic health is tied to aging, these medications could influence aging processes.10
“GLP-1 agonists decrease the incidence of diseases that are related to aging and are associated with decreasing life span,” Dr. Musi noted.
Despite the promising findings, concerns about side effects, such as muscle loss and lower bone density, remain significant, particularly for older adults.4
As more clinical trials are set to explore the effects of GLP-1 drugs on aging markers, the scientific community continues to monitor their potential as longevity treatments.9
“Recent studies indicate that weight loss drugs, particularly Ozempic, could have benefits related to longevity and biological aging. However, researchers emphasize that more evidence is needed before these drugs can be recommended for anti-aging purposes.”
Men's Journal
AOL.com
